HOUSTON, Oct. 13, 2016 -- Frank’s International N.V. (the “Company”) (NYSE:FI) announced today that it will host a conference call to discuss its third quarter 2016 results on Thursday, November 3, 2016 at 10:00 a.m. Central Time (11:00 a.m. Eastern Time). The Company will issue its third quarter 2016 earnings release prior to the conference call.
Participants may join the conference call by dialing (888) 771-4371 or (847) 585-4405. The conference call ID number is 43595337. To listen via live webcast, please visit the Investor Relations section of the Company's website, www.franksinternational.com.
An audio replay of the conference call will be available approximately two hours after the conclusion of the call. The audio replay will remain available for seven days by dialing (888) 843-7419 or (630) 652-3042. The conference call audio replay access code is 43595337. The audio replay will also be available in the Investor Relations section of the Company’s website approximately two hours after the conclusion of the call and remain available for a period of approximately 90 days.
Frank’s International N.V. is a global oil services company that provides a broad and comprehensive range of highly engineered tubular services to leading exploration and production companies in both offshore and onshore environments, with a focus on complex and technically demanding wells. Founded in 1938, Frank’s has approximately 3,000 employees and provides services in approximately 60 countries on six continents. The Company’s common stock is traded on the NYSE under the symbol “FI.” Additional information is available on the Company’s website, www.franksinternational.com.
Contacts: Blake Holcomb – Director, Investor Relations [email protected] 713-231-2463 Karen Allen – Director, Communications and External Affairs [email protected] 713-358-7325


FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Italy Fines Apple €98.6 Million Over App Store Dominance
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 



